Cargando…

Response to Letter to the Editor: “Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History”

Detalles Bibliográficos
Autores principales:	Schini, Marian, Eastell, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Online Only Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7271762/ https://www.ncbi.nlm.nih.gov/pubmed/32422658 http://dx.doi.org/10.1210/clinem/dgaa278

Ejemplares similares

Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History
por: Schini, Marian, et al.
Publicado: (2020)

Normocalcemic primary hyperparathyroidism
por: Cusano, Natalie E., et al.
Publicado: (2022)

Response to Letter to the Editor from Liu et al: “Evidence in Support for the Progressive Nature of Ovarian Endometriomas”
por: Liu, Xishi, et al.
Publicado: (2020)

Response to Letter to the Editor: “Changes in Thyroid Function Across Adolescence: A Longitudinal Study”
por: Campbell, Purdey J, et al.
Publicado: (2020)

Response to Letter to the Editor: “Trends in Endocrinology Fellowship Recruitment: Reasons for Concern and Possible Interventions”
por: Romeo, Giulio R, et al.
Publicado: (2020)

Response to Letter to the Editor: “Checkpoint Inhibitor-Associated Autoimmune Diabetes is Distinct From Type 1 Diabetes”
por: Tsang, Venessa H M, et al.
Publicado: (2020)

Comparisons Between Normocalcemic Primary Hyperparathyroidism and Typical Primary Hyperparathyroidism
por: Choi, Hye Ryeon, et al.
Publicado: (2022)

Response to Letter to the Editor: “IGSF1 Deficiency Results in Human and Murine Somatotrope Neurosecretory Hyperfunction”
por: Joustra, Sjoerd D, et al.
Publicado: (2020)

Normocalcaemic hyperparathyroidism and primary hyperparathyroidism: least significant change for adjusted serum calcium
por: Schini, Marian, et al.
Publicado: (2020)

Response to Letter to the Editor From Asa and Mete: “Hypophysitis, the Growing Spectrum of a Rare Pituitary Disease”
por: Langlois, Fabienne, et al.
Publicado: (2022)

Response to Letter to the Editor from Soghomonian: “Epicardial and Pericardial Adiposity Without Myocardial Steatosis in Cushing Syndrome”
por: Wolf, Peter, et al.
Publicado: (2021)

Response to Letter to the Editor From Asadipooya: “Obesity and COVID-19: Mechanistic Insights From Adipose Tissue”
por: Yu, Lili, et al.
Publicado: (2022)

Response to Letter to the Editor From Laidlaw: “Erythrocytosis in a Large Cohort of Trans Men Using Testosterone: A Long-term Follow-up Study on Prevalence, Determinants, and Exposure Years”
por: Madsen, Milou C, et al.
Publicado: (2021)

Response to Letter to the Editor from Berends et al: “Approach to the Patient: Perioperative Management of the Patient With Pheochromocytoma or Sympathetic Paraganglioma”
por: Berends, Annika M A, et al.
Publicado: (2020)

Response to Letter to the Editor From Jialal: “Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Disease: A Longitudinal Study”
por: Lee, Iris, et al.
Publicado: (2022)

Letter to the Editor: “Exercise Training Adaptations in Metabolic Syndrome Individuals on Chronic Statin Treatment”
por: Allard, Neeltje A E, et al.
Publicado: (2020)

Response to Letter to the Editor From Bonnema et al: “Comparative Effectiveness of Levothyroxine, Desiccated Thyroid Extract, and Levothyroxine + Liothyronine in Hypothyroidism”
por: Shakir, Mohamed K M, et al.
Publicado: (2021)

Response to Letter to the Editor from Youn Hee Jee: “Familial Short Stature - A Novel Phenotype of Growth Plate Collagenopathies”
por: Plachy, Lukas, et al.
Publicado: (2021)

MON-541 Successful Treatment of Normocalcemic Hyperparathyroidism in Children
por: Papadimitriou, Dimitrios, et al.
Publicado: (2019)

Normocalcemic Hyperparathyroidism: A Heterogeneous Disorder Often Misdiagnosed?
por: Zavatta, Guido, et al.
Publicado: (2020)

Renal Papillary Necrosis Associated With Normocalcemic Primary Hyperparathyroidism
por: Ebrahim, Ismail C., et al.
Publicado: (2020)

Response to Letter to the Editor From Behar-Cohen et al.: The Cortisol Response of Male and Female Choroidal Endothelial Cells: Implications for Central Serous Chorioretinopathy
por: Brinks, Joost, et al.
Publicado: (2021)

Response to Letter to the Editor from Giovanelli and Quinton: “Distinguishing Self-limited Delayed Puberty From Permanent Hypogonadotropic Hypogonadism: How and Why?”
por: Harrington, Jennifer, et al.
Publicado: (2021)

Response to Letter to the Editor From Taguchi: “Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS”
por: Anastasilakis, Athanasios D, et al.
Publicado: (2022)

Response to Letter to the Editor From Cuny et al: “Correlation of Preoperative Imaging Findings and Parathyroidectomy Outcomes Support NICE 2019 Guidance”
por: Chander, Nikita R, et al.
Publicado: (2022)

Response to Letter to the Editor From Berruti et al: “Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients’ Survival”
por: Srougi, Victor, et al.
Publicado: (2022)

Response to Letter to the Editor from Edmundo Avila-Hipolito: “Long-Term Effects of Radioiodine in Toxic Multinodular Goiter: Thyroid Volume, Function, and Autoimmunity”
por: Pilli, Tania, et al.
Publicado: (2020)

Response to Letter to the Editor From Malozowski: “Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial”
por: Thornton, Paul S, et al.
Publicado: (2021)

Response to Letter to the Editor from McKee and McGill: “Glycemic Control and Variability of Diabetes Secondary to Total Pancreatectomy Assessed by Continuous Glucose Monitoring”
por: Juel, Caroline T B, et al.
Publicado: (2021)

Response to Letter to the Editor from Roy et al: “Impaired Suppression of Glucagon in Obese Subjects Parallels Decline in Insulin Sensitivity and Beta-Cell Function”
por: Chen, Xi, et al.
Publicado: (2021)

Response to Letter to the Editor From Singhania et al.: “Increasing Incidence of Primary Aldosteronism in Western Sweden During 3 Decades – Yet an Underdiagnosed Disorder”
por: Gkaniatsa, Eleftheria, et al.
Publicado: (2021)

Response to Letter to the Editor From Green and Gosmanov: “Tall Cell Percentage Alone in PTC Without Aggressive Features Should not Guide Patients’ Clinical Management”
por: Viola, David, et al.
Publicado: (2022)

Response to Letter to the Editor from Lasolle and Raverot: “USP8 and TP53 Drivers Are Associated with CNV in a Corticotroph Adenoma Cohort Enriched for Aggressive Tumors”
por: Uzilov, Andrew V, et al.
Publicado: (2021)

Evaluation of coronary calcium score in patients with normocalcemic primary hyperparathyroidism
por: Mesquita, Patrícia Nunes, et al.
Publicado: (2017)

SAT-363 Renal Papillary Necrosis Associated with Normocalcemic Hyperparathyroidism
por: Shakir, Mohamed K M, et al.
Publicado: (2020)

Normocalcemic Primary Hyperparathyroidism Presenting with Muscle Weakness and Body Pain
por: Mihashi, Izumi, et al.
Publicado: (2020)

Normocalcemic Primary Hyperparathyroidism: Need for a Standardized Clinical Approach
por: Zavatta, Guido, et al.
Publicado: (2021)

Genetic aspects underlying the normocalcemic and hypercalcemic phenotypes of primary hyperparathyroidism
por: Viviani, Arianna, et al.
Publicado: (2023)

Response to Letter to the Editor From Pattan et al: “U-shaped Association Between Dietary Zinc Intake and New-onset Diabetes: A Nationwide Cohort Study in China”
por: He, Panpan, et al.
Publicado: (2022)

Letter to the Editor: “Lavender Products Associated With Premature Thelarche and Prepubertal Gynecomastia: Case Reports and Endocrine-Disrupting Chemical Activities”
por: Giroux, Jean-Marc, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qj9612nbr7lsi66sn8ea7j0e3m